1.Effect of desogestrel and ethinyl estradiol pretreatment in superovulation cycles with short protocol
Junzhao ZHAO ; Xianhua LIN ; Xuefeng HUANG ; Jinju LIN ; Wenqin LIN ; Bilü YE
Chinese Journal of Obstetrics and Gynecology 2008;43(2):102-105
Objective To explore the prevalence of nonalcoholic fatty liver disease(NAFLD)in patients with polycystic ovary syndrome(PCOS).MethodsA case-control study employing 60 non pregnant patients with PCOS and 60 non-pregnant patients without PCOS as control was conducted to compare the prevalence of NAFLD.Resuits The aminotransferase(ALT),fasting insulin and homeostasis model assessment of insulin resistance(HOMA-IR)levels were(29±15)U/L,(19±12)mU/L and 0.47±0.29 in PCOS group,which were significantly higher(P<0.05)than corresponding parameters in control group[(15±13)U/L,(11±8)mU/L and 0.31±0.21)].The occurrence of insulin resistance and NAFLD was 63%(38/60)and 42%(25/60),higher than those in control group[35%(21/60)and 20%(12/60),P<0.05].The increment of ALT was 40%(24/60)in PCOS group,higher than that of 3%(2/60)in control group(P<0.01).Compared with patients witIlout NAFLD,patients with NAFLD had significantly increased body mass index(P<0.01),waist-hip ratio,AIJT,C-reaction protein,fasting insulin,insulin and HOMA-IR levels 2 hours after oral glucose tolerance test(P<0.05).Conchsion The increased prevalence of NAFLD in PCOS patients suggests an association between these two conditions and the necessity of hepatic screening among PCOS patients for potential NAFLD.
2.Comparision of in vitro maturation applied in PCOS and non-PCOS patients undergo stimulated and unstimulated protocols
Peiyu WANG ; Junzhao ZHAO ; Congcong JIN ; Rong YU ; Jia LIN ; Ruru ZHU ; Yonggen WU
Chinese Journal of Obstetrics and Gynecology 2014;49(12):903-908
Objective To compare the laboratory and clinical results between unstimulated in vitro maturation (IVM) and IVM converted from in vitro fertilization (IVF) in polycystic ovarian syndrome (PCOS) and non-PCOS patients.Methods We divided 591 IVM cycles in the First Affiliated Hospital of Wenzhou Medical Univesity from Jan.2008 to Dec.2013 into 4 groups:group A1B1,PCOS patients underwent unstimulated IVM protocol,240 cycles; group A1B2,PCOS patients underwent IVM converted from conventional stimulated IVF protocol,153 cycles; group A2B1,non-PCOS patients underwent unstimutlated IVM protocol,103 cycles; group A2B2,non-PCOS patient underwent IVM converted from conventional stimulated IVF protocol,95 cycles.Multiple linear regression method and binary logistic regression method were used to assess the influence of PCOS and protocols for IVM on laboratory and clinical outcomes.Results The mean number of oocytes retrieved was positively related with PCOS [partial regression coefficient (B)=3.37,P<0.01].The maturation rate of oocytes was positively related with hCG-prime prior to oocyte aspiration (B=0.05,P=0.010).High-quality embryo rate was positively related with PCOS and IVM converted from IVF (B=0.08,P=0.010; B=0.09,P=0.001),as well as implantation rate related with them (B=0.07,P=0.010; B=0.10,P<0.01).PCOS and IVM converted from IVF improved hCG positive (hCG>10 U/L) rate (OR=1.636,95%CI:1.113-2.204,P<0.05; OR=1.861,95%CI:1.307-2.649,P<0.05) and the clinical pregnancy rate (OR=1.507,95%CI:1.041-2.240,P<0.05; OR=1.881,95%CI:1.312-2.696,P<0.05).IVM converted from IVF protocol decreased the spontaneous abortion rate (OR=0.490,95%CI:0.245-0.978,P<0.05).Multiple gestation rate and ectopic pregnancy rate were not affected by PCOS condition and protocol used (P>0.05).Conclusions PCOS and IVM converted from IVF protocol improved the high-quality embryo rate,implantation rate,hCG positive rate and clinical pregnancy rate.IVM converted from IVF protocol reduced the spontaneous abortion rate.PCOS patients may be more suitable for the IVM treatment.No matter PCOS or non-PCOS patients,IVM converted from IVF protocol had better pregnancy outcome than that of unstimulated cycle.
3.Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome
Ruru ZHU ; Shiquan XIAO ; Junzhao ZHAO ; Jia LIN ; Peiyu WANG ; Congcong JIN ; Wumin JIN
Chinese Journal of Obstetrics and Gynecology 2013;48(11):833-837
Objective To compare the outcomes of in-vitro maturation (IVM) and in-vitro fertilization (IVF) after early follicular phase gonadotropin-releasing hormone agonist (GnRH-a)down-regulation in infertile patients with polycystic ovary syndrome (PCOS).Methods From July 2010 to December 2012,72 infertile patients with PCOS undergoing assisted reproductive technology treatment in the Affiliated First Hospital of Wenzhou Medical University were enrolled in this study.The patients were divided into 2 groups,which were patients with early follieular phase down-regulation IVM (36 cases) at IVM group and early follicular phase down-regulation long protocol IVF (36 cases) at IVF group.The laboratory parameters and clinical outcomes were compared between two groups.Results (1) Lab parameters:a total of 442 oocytes were retrieved in group IVM,and 560 were in group IVF.The rate of mature oocytes of 83.8% (469/560) and high-quality embryos of 70.9% (212/299) at group IVF were significantly higher than that of group IVM [54.1% (239/442) and 50.7% (73/144),retrospectively,P <0.01].In group IVM,the average duration of gonadotropin (Gn) was (2.8 ± 1.5) days and the average dosage of Gn was (285 ± 169) U,which were significantly lower than (11.0 ± 1.0) days and (1499 ±165) U in group IVF (P <0.01).The mean number of oocytes retrieved 12.8 ± 2.5,fertilization rate of 64.8% (155/239),and implantation rate of 31% (23/74) in group IVM and 15.6 ±3.1,65.5% (307/469),31% (23/74) in group IVF,which did not reach statistical difference (P >0.05).(2) Clinical outcomes:the clinical pregnancy rate (17/31,55%) of IVF group was not significantly higher than that 44% (14/32) at IVM group (P > 0.05).The abortion rate was 1/17 at Group IVF and 1/14 in group IVM,which did not show statistical difference.Women at IVM group has no ovarian hyper-stimulation syndrome (OHSS) cycle,group IVF has 31% (11/36) cycles presented moderate and severe OHSS.Conclusions Infertile patients with PCOS undergoing IVM and IVF treatment after early follicular phase GnRH-a down-regulation can get satisfactory laboratory and clinical outcome.In addition to short treatment cycle,IVM can also avoid the occurrence of OHSS completely,but it has a rising trend in the abortion rate.IVF has a high incidence of OHSS,meanwhile,it increases the dosage of gonadotropins.
4.Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer
Rong YU ; Jia LIN ; Junzhao ZHAO ; Peiyu WANG ; Shiquan XIAO ; Wei ZHANG
Chinese Journal of Obstetrics and Gynecology 2012;47(4):250-254
ObjectiveTo compare clinical and laboratory outcomes of in vitro maturation (IVM) with in vitro fertilization-embryo transfer (IVF-ET) in treatment of infertility associated with polycystic ovary syndrome (PCOS).MethodsFrom Jan.2007 to Dec.2010,infertile patients with PCOS underwent 701 cycles in First Affiliated Hospital of Wenzhou Medical College were studied retrospectively.Those were divided into 293 cycles of IVM group and 408 cycles of IVF/intra-cytoplasmic sperm injection ( ICSI ) group.The average transplantation rate,mean number of retrieval oocytes,maturation rate,fertilization rate,cleavage rate,high quality embryo rate,embryo implantation rate,pregnancy rate per transfer,pregnancy outcomes and incidence of ovarian hyperstimulation syndrome (OHSS) of the two methods of treatment were compared between two groups.ResultsThere were 275 cycles in IVM group and 342 cycles in IVF/ICSI group established embryo transfer.The transplantation rate was 93.9%(275/293)in IVM group and 83.8% (342/408) in IVF/ICSI,which reached statistical difference (P < 0.01 ).The maturation rate of 56.64%,cleavage rate of 88.08%,high quality embryo rate of 38.72% and embryo implantation rate of 17.8% in IVM group were significantly lower than 91.09%,94.91%,51.50% and 25.4% in IVF/ICSI group (all P < 0.01 ).The clinical pregnancy rate per transfer were 37.8% (104/275) in IVM group and 44.2% (151/342) in IVF/ICSI group,which did not show statistical difference (P>0.05).The mean number of oocytes ( 12.9 ±6.5 vs.12.9 ±7.9) and fertilization rate (76.52% vs.70.75% ) didn't show significant difference between IVM group and IVF/ICSI group ( P > 0.05 ).The 21.3% ( 87/408 ) cycles presented mild to moderate OHSS and 2.0%cycles(8/408)presented severe OHSS in IVF/ICSI group.While,no OHSS cycles were observed in IVM group.Conclusion IVM could get similar clinical pregnancy rates compared with IVF/ICSI in patient with PCOS,however,it can avoid occurrence of OHSS.
5.Clinical study on in vitro maturation of immature oocytes transferred from conventional in vitro fertilization
Peiyu WANG ; Junzhao ZHAO ; Wei ZHANG ; Jinju LIN ; Shiquan XIAO ; Yonggen WU ; Xuefeng HUANG
Chinese Journal of Obstetrics and Gynecology 2009;44(12):924-928
Objective To investigate clinical effect of in vitro maturation(IVM)of immature oocytes transferred from conventional in vitro fertilization embryo transfer(IVF-ET) cycles.Methods From January 2008 to June 2009.medical documents of 155 infertile patients underwent IVF-ET in the Reproductive Medical Center of Fimt Affiliated Hospital of Wenzhou Medical College were analyzed retrospectively.If more than 20 oocytes were monitored after 5-7 days of ovulation induction or follicular developmental retardation were confirmed after 8-13 days of ovulation induction.according to patients' wish,IVM were transferred in 60 cycles(group A).In the mean time.IVF was continued in 95 cycles (group B).The mean dosage of gonadotropin,the cancel lation rate of cycles,the mean numbers of oocytes retrieved and maturation,the rate of fertilization and excellent quality embryos.pregnancy outcome and the incidence rate of ovarian hyperstimulation syndrome(OHSS)were compared and analyzed.Results The rates of embryo transfer were 92%(55/60)in group A and 63%(60/95)in group B,which showed significant differences (P<0.05).In group A,the mean dosage of the gonadotropin,the mean number of oocytes retrieved,the cleavage rate and OHSS rate were(1030±468)U,10±6,82.2%(231/281)and O,and were(1544±338)U,14±4,94.0%(502/534)and 35%(21/60)in group B,respectively,all data abeve exhibited statistieal difference between two groups(P<0.05).However,the rates of fertilization and excellent quality embryos had no significant differences between two groups(P>0.05).In group A,the rate of clinical pregnancy per transfer was 53%(29/55)and multiple pregnancy was 14%(4/29),and were 47%(28/60) and 32%(9/28)in group B,they all had no significant differences (P>0.05).Conclusion IVM of immature oocytes used in conventional IVF cycles not only obtained a high clinical pregnancy rate,but also reduced gonadotropin using dosage and avoided OHSS completely.
6.Incidence and management of monozygotic twin conceived by assisted reproductive techniques
Lijing MO ; Congcong JIN ; Yonggen WU ; Peiyu WANG ; Jia LIN ; Junzhao ZHAO
Chinese Journal of Obstetrics and Gynecology 2015;(8):586-590
Objective To analysis the incidence and management of monozygotic twin (MZT) conceived by assisted reproductive techniques (ART). Methods A retrospective analysis of clinical pregnancies and MZT that resulted from ART was performed in Reproductive Medical Center,the First Affiliated Hospital,Wenzhou Medical University between January 2011 and January 2014. Results A total of 5 908 pregnancies were diagnosed: 2 012 twins, 157 high-order multiple pregnancy (HOMP), including 4 quadruplets. Overall, 51 MZT pregnancies were identified of them including 32 cases HOMP and 19 cases MZT. The incidence of MZT resulting from cleavage-stage embryo transfer was similar to blastocyst transfer (P=0.960). The percent of MZT resulting from in vitro fertilization [0.93% (28/3 022)], frozen-thawed embryo transfer [0.87% (13/1 502)] and intracytoplamic sperm injection [0.72% (10/1 384)] did not show statistical significance (P=0.794). The expectantly managed MZT was associated with a significantly greater likelihood of miscarriage [6/19 vs 5.11% (101/1 976)], and low birth weight infant [73.91% (17/23) vs 42.89% (1 453/3 388), P<0.01], when compared with dizygotic twin (DZT) did not undergo selective embryo reduction(SER). In monozygotic (MZ)-triplets with SER to 2 fetuses or to 1 fetus, there was no cases of preterm birth or low birth weight infant observed in MZ-triplets with SER to 1 fetus;when compared with MZ-triplets with SER to 2 fetuses, the low birth weight infant [56.00% (14/25), P=0.021] has statistical significance. The likelihood of the survival of two babies was lower in MZ-triplets with SER to 2 fetuses when compared with non-MZ triplets with SER to 2 fetuses [42.86%(9/21)vs 75.21%(91/121), P=0.003]. Conclusions The incidence of MZT pregnancies following ART is high. It plays a significant role in the occurrence of HOMP. MZT pregnancies are at an increased risk of adverse outcomes , it should transform to a single embryo thansfer (SET) program to reduce them incideuce. Reduction of MZT contained in multiple pregnancies appears to be a safe option.
7.Dual-source variable pitch spiral CT reconstruction algorithm.
Jun ZHAO ; Zungang LIU ; Yannan JIN ; Tiange ZHUANG
Journal of Biomedical Engineering 2008;25(6):1249-1253
Computed tomography angiography (CTA) is a useful approach for diagnosing vascular diseases. In this paper, we proposed a reconstruction algorithm for dual-source spiral CT with variable pitch. The projection data are collected by the double-source double-multislice spiral CT (DSDMS-CT). However, the pitch of the DSDMS-CT is variable other than being constant. We have developed a new formula performing interpolation along Z-axis for dual-source spiral CT with variable pitch. The dual-source spiral CT with variable pitch can chase contrast bolus more flexibly and more effectively. The simulation results show the correctness and efficiency of the proposed algorithm.
Algorithms
;
Coronary Angiography
;
methods
;
Humans
;
Tomography, Spiral Computed
;
instrumentation
;
methods
8.Outcome of pregnancy in women with polycystic ovary syndrome treated by in vitro maturation of immature oocytes
Junzhao ZHAO ; Xia CHEN ; Peiyu WANG ; Wei ZHOU ; Jinju LIN ; Wei ZHANG ; Xuefeng HUANG ; Wenqin LIN ; Haiyan YANG ; Ya CHEN
Chinese Journal of Obstetrics and Gynecology 2009;44(6):409-412
n occurring after the treatment of IVM in women with PCOS are not mounting. However, the relative high rates of multiple pregnancies, low birth weight and preterm labor were increased.
9.Cell Count of Mouse Blastocyst on Pre-clinical Evaluation of Safety of Medical Devices in Assisted Reproductive Technologies.
Qianqian HAN ; Junzhao ZHAO ; Zhaopeng YANG ; Jianfeng SHI ; Ying WANG ; Huan LIAN ; Chunren WANG ; Xingliang JIN
Chinese Journal of Medical Instrumentation 2018;42(4):289-292
Various types of medical devices used in assisted reproductive technologies (ART) should be detected for their safety by strict biological assays. Mouse embryo assay(MEA)has been recognized as one of the most important and standardized methods with the threshold more than 80% of blastocyst formation rate (BR) after 96 h culture of fertilized eggs. The disadvantage using BR for embryonic quality control has been concerned as it is ubiquitously dependent of embryonic morphology and the detailed data including molecular and genetic information is obviously missing and incomplete. This leads to the urgent requirement for more sensitive and efficient assessments for the quality control of ART. This study evaluated the reliability of an immunofluorescent MEA by counting total cell and differential number of the cells in the inner cell mass (ICM) and trophectoderm (TE) in the blastocyst. This method improved the traditional MEA, provided a sensitive and powerful platform to assess embryonic developmental viability and should be suggested as a standard assay to be globally used for the quality control of medical devices and pre-clinical procedures in ART.
Animals
;
Blastocyst
;
Embryonic Development
;
Equipment Safety
;
Mice
;
Reproducibility of Results
;
Reproductive Techniques, Assisted
;
instrumentation
10.Can SpRY recognize any PAM in human cells?
Jinbin YE ; Haitao XI ; Yilu CHEN ; Qishu CHEN ; Xiaosheng LU ; Jineng LV ; Yamin CHEN ; Feng GU ; Junzhao ZHAO
Journal of Zhejiang University. Science. B 2022;23(5):382-391
The application of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) can be limited due to a lack of compatible protospacer adjacent motif (PAM) sequences in the DNA regions of interest. Recently, SpRY, a variant of Streptococcus pyogenes Cas9 (SpCas9), was reported, which nearly completely fulfils the PAM requirement. Meanwhile, PAMs for SpRY have not been well addressed. In our previous study, we developed the PAM Definition by Observable Sequence Excision (PAM-DOSE) and green fluorescent protein (GFP)-reporter systems to study PAMs in human cells. Herein, we endeavored to identify the PAMs of SpRY with these two methods. The results indicated that 5'-NRN-3', 5'-NTA-3', and 5'-NCK-3' could be considered as canonical PAMs. 5'-NCA-3' and 5'-NTK-3' may serve as non-priority PAMs. At the same time, PAM of 5'-NYC-3' is not recommended for human cells. These findings provide further insights into the application of SpRY for human genome editing.
CRISPR-Associated Protein 9/metabolism*
;
CRISPR-Cas Systems
;
DNA
;
Gene Editing/methods*
;
Humans
;
Streptococcus pyogenes/metabolism*